##plugins.themes.academic_pro.article.main##

Abstract

Chronic heart failure (CHF) is one of the most significant medical and social pathologies characterized by a high prevalence and mortality. According to experts, CHF in Western countries occurs in 1-2% of the general population, reaching 10% in people over 70 years of age. In the Russian Federation, CHF is diagnosed in 7–10% of cases, while more than 65% of Russian patients are people over 60 years old. In the structure of mortality from diseases of the circulatory system, CHF occupies one of the leading positions [9, 13, 15, 16].


Among the reasons leading to the development of CHF, arterial is traditionally considered -hypertension (AH) and coronary heart disease (CHD), which occupy the largest share in the structure of nosologies that cause the formation of heart failure (95.5% and 69.7%, respectively). The classical causes of CHF (heart defects, cardiomyopathies , myocarditis, etc.) are less common. At the same time, one of the frequent and significant diseases characterized by the early development of heart failure is type 2 diabetes mellitus (DM), which has been shown in a number of studies.


In the Russian Federation, DM ranks third (15.9%) among the causes of CHF [9, 13, 14]. In addition, the occurrence and progression of heart failure in patients with DM is one of the main causes of death in this cohort of patients.


 

Keywords

diabetes mellitus, pharmacotherapy, ischemic cardiomyopathy, hypoglycemia, a multidisciplinary approach.

##plugins.themes.academic_pro.article.details##

How to Cite
Xaydarova M.K., & Scientific supervisor Yusupova Sh.K. (2022). Mutual influence of heart failure on the course of type 2 diabetes mellitus. Texas Journal of Medical Science, 14, 153–158. https://doi.org/10.62480/tjms.2022.vol14.pp153-158

References

Read More